SynthesisThe Journal of international medical research2020

A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer.

Guan-Li Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.